1. Home
  2. NBY vs DOMO Comparison

NBY vs DOMO Comparison

Compare NBY & DOMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$15.78

Market Cap

398.2M

Sector

N/A

ML Signal

HOLD

Logo Domo Inc. Class B

DOMO

Domo Inc. Class B

HOLD

Current Price

$6.16

Market Cap

477.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBY
DOMO
Founded
2000
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
398.2M
477.0M
IPO Year
2007
2018

Fundamental Metrics

Financial Performance
Metric
NBY
DOMO
Price
$15.78
$6.16
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$15.22
AVG Volume (30 Days)
3.2M
958.7K
Earning Date
11-07-2025
03-05-2026
Dividend Yield
6.30%
N/A
EPS Growth
N/A
N/A
EPS
0.47
N/A
Revenue
$10,302,000.00
$318,002,000.00
Revenue This Year
$23.91
$2.28
Revenue Next Year
$32.05
$2.84
P/E Ratio
$493.09
N/A
Revenue Growth
390.34
N/A
52 Week Low
$0.46
$6.01
52 Week High
$19.95
$18.49

Technical Indicators

Market Signals
Indicator
NBY
DOMO
Relative Strength Index (RSI) 69.49 18.77
Support Level $10.42 $8.06
Resistance Level $19.95 $8.83
Average True Range (ATR) 3.14 0.39
MACD 0.59 -0.13
Stochastic Oscillator 73.24 3.70

Price Performance

Historical Comparison
NBY
DOMO

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

About DOMO Domo Inc. Class B

Domo Inc provides a cloud-based platform that digitally connects all the data, systems, and people in an organization, giving them access to real-time data and insights and allowing them to manage their business from their smartphones. The company offers a platform to its customers as a subscription-based service. Users receive notifications on any device and immediately act on the invitation, after which the system can write back to the original system of record. The company derives revenue from subscriptions to its cloud-based platform and professional services.

Share on Social Networks: